Glaxo (GSK) Confirms Offer for Human Genome (HGSI), Deal Valued at $14.25/Share in Cash

Go back to Glaxo (GSK) Confirms Offer for Human Genome (HGSI), Deal Valued at $14.25/Share in Cash